These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4072 related articles for article (PubMed ID: 3810424)

  • 21. Results of hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
    Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of regional melanoma therapy.
    Padsis J; Turley R; Tyler D
    Expert Opin Pharmacother; 2010 Jan; 11(1):79-93. PubMed ID: 20001431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
    Schraffordt Koops H; Oldhoff J
    Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extremity perfusion in malignant melanoma].
    Hohenberger W; Meyer T; Göhl J
    Chirurg; 1994 Mar; 65(3):175-85. PubMed ID: 8194401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.
    Liénard D; Eggermont AM; Schraffordt Koops H; Kroon BB; Rosenkaimer F; Autier P; Lejeune FJ
    Melanoma Res; 1994 Mar; 4 Suppl 1():21-6. PubMed ID: 8038591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
    J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant chemotherapy in addition to radical surgical treatment of regional lymph node metastases in malignant melanoma].
    Czarnetzki BM; Aragon V; Bröcker EB; Krieg V; Bünte H; Macher E
    Dtsch Med Wochenschr; 1986 May; 111(19):732-6. PubMed ID: 3698850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
    King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 32. Regional chemotherapy by isolation-perfusion.
    McBride CM; McMurtrey MJ; Copeland EM; Hickey RC
    Int Adv Surg Oncol; 1978; 1():1-9. PubMed ID: 553035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical results of extremity perfusion in malignant melanoma].
    Huber R; Stützer H; Krüger I
    Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional lymph node dissection for malignant melanoma of the extremities.
    Roses DF; Harris MN; Gumport SL; Michelassi F; Coffey JA; Dubin N
    Surgery; 1981 Jun; 89(6):654-9. PubMed ID: 7245026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 204.